Honokiol in Immunometabolic Assay Design: Beyond NF-κB Inhib
2026-07-01
Explore how Honokiol, a potent NF-κB pathway inhibitor, uniquely empowers advanced immunometabolic assay design by integrating metabolic flexibility insights. This article provides a deep dive into mechanistic detail, protocol optimization, and translational strategy—unlike any existing resource.
Optimizing Dye Use for Small Biopsy Visualization in Patholo
2026-07-01
This article reviews a 2023 study evaluating the effectiveness of various dyes for marking small tissue biopsies in surgical pathology. The findings clarify which dyes best enhance tissue visibility during processing, with practical implications for minimizing sample loss and diagnostic errors.
X-ray Triggered Nuclear Doxorubicin Release via Nanomicelles
2026-06-30
Yao et al. present a novel chemoradiation approach wherein X-ray-induced Cherenkov emission activates the release of caged doxorubicin from folate-targeted nano-micelles, achieving precise nuclear drug delivery and significant tumor eradication in vivo. This strategy addresses the longstanding challenge of balancing chemotherapeutic efficacy with off-target toxicity, offering translational promise for localized cancer therapy.
Patient-Derived Gastric Cancer Assembloids: Modeling Tumor-S
2026-06-30
This study introduces a patient-specific gastric cancer assembloid model that integrates matched tumor organoids with stromal cell subpopulations, closely recapitulating the tumor microenvironment. The approach enables more physiologically relevant drug response assays, facilitating research on resistance mechanisms and advancing personalized therapy strategies.
Mutational Drivers and Drug Resistance in Multiple Myeloma C
2026-06-29
The reference study provides the first comprehensive exome sequencing of 30 human multiple myeloma cell lines, uncovering recurrently mutated genes and pathway alterations that underlie tumor heterogeneity and drug resistance. These findings enable more precise model selection and inform targeted research strategies in hematological malignancy.
Technical Guide: 0.4% Trypan Blue Solution in Cell Viability
2026-06-29
0.4% Trypan Blue Solution provides a direct, membrane-exclusion method for discriminating live from dead cells, supporting accurate cell viability measurement and cell counting in research workflows. It is not intended for diagnostic or clinical use, nor for detection of early-stage apoptosis or necrosis. Use is recommended in controlled laboratory settings with standardized protocols.
Novobiocin: Applied Workflows for Antiparasitic and Antivira
2026-06-28
Novobiocin’s dual action as an aminocoumarin antibiotic and Hsp90 inhibitor enables streamlined experimental workflows across antibacterial, antiparasitic, and antiviral domains. This guide delivers protocol-ready insights, advanced troubleshooting, and data-driven strategies to help researchers leverage Novobiocin for next-generation infectious disease studies.
BMS 599626 Dihydrochloride: EGFR and ErbB2 Inhibitor Workflo
2026-06-27
BMS 599626 dihydrochloride empowers cancer research with its potent, nanomolar inhibition of EGFR and ErbB2, offering precise control of oncogenic signaling in breast and lung cancer models. This guide details optimized protocols, advanced applications, and troubleshooting strategies to maximize experimental impact with APExBIO’s trusted reagent.
Molnupiravir Suppresses Bourbon Virus Pathology in Mouse Mod
2026-06-26
This study demonstrates that molnupiravir, a broad-spectrum nucleoside analogue, robustly inhibits Bourbon virus replication and associated pathology in mice. The work identifies molnupiravir as a leading candidate for preclinical development against emerging tick-borne RNA viruses that currently lack approved antiviral therapies.
Cyclic di-GMP Regulates Biofilm Genome Stability and Persist
2026-06-26
Liao et al. (2024) identify cyclic di-GMP as a small-molecule antitoxin controlling both genome integrity and antibiotic persistence in bacterial biofilms. This mechanistic advance reframes how toxin-antitoxin systems contribute to biofilm resilience and offers new directions for infection research.
Pronase E Protease Mixture: Precision Protein Digestion Work
2026-06-25
Pronase E, a high-activity protease mixture from APExBIO, unlocks reproducible protein and peptide mapping for advanced proteomics and translational oncology workflows. Discover how its broad substrate range, protocol versatility, and troubleshooting strategies empower rigorous sample preparation and mechanistic studies—especially in complex contexts like ferroptosis research.
PPM-18 and the NF-κB/iNOS Axis: Precision Tools for Advanced
2026-06-25
Explore how PPM-18, a potent N-(1,4-dihydro-1,4-dioxo-2-naphthalenyl)-benzamide, enables precise modulation of iNOS and NF-κB signaling in inflammation and sepsis models. This article delivers a unique, assay-focused analysis with actionable insights for translational researchers.
YTHDF2 Inhibition Boosts Protein Synthesis and Memory in Mic
2026-06-24
This study demonstrates that forebrain-specific knockout of YTHDF2, a key m6A reader protein, enhances synaptic protein synthesis and hippocampus-dependent memory in mice. These findings clarify the role of m6A-mediated mRNA degradation in neuroplasticity and suggest new molecular targets for cognitive intervention.
Pertussis Toxin in Immune Modulation: Protocols & Troublesho
2026-06-23
Pertussis toxin is a gold-standard AB5-type protein exotoxin used for precise immune response modulation, particularly in dissecting cAMP signaling and T helper cell differentiation. This guide unpacks applied workflows, troubleshooting strategies, and the translational impact of using high-purity APExBIO Pertussis toxin in immunological and vascular research.
Metal-Ion Chelating L-Phe Nanostructures Enhance Tumor Immun
2026-06-23
This study demonstrates that metal-ion-chelating L-phenylalanine nanostructures, when combined with short-term starvation, remodel the immunosuppressive tumor microenvironment and sensitize breast tumors to immune checkpoint blockade. The work introduces a mechanism by which nanostructures modulate dendritic cell electrophysiology, offering a new strategy for improving immunotherapy outcomes.
470 records 14/32 page Previous Next First page 上5页 1112131415 下5页 Last page